tradingkey.logo

Nuwellis Inc

NUWE
3.750USD
-0.100-2.60%
收盘 02/02, 16:00美东报价延迟15分钟
5.12M总市值
0.02市盈率 TTM

Nuwellis Inc

3.750
-0.100-2.60%

关于 Nuwellis Inc 公司

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Nuwellis Inc简介

公司代码NUWE
公司名称Nuwellis Inc
上市日期Feb 16, 2012
CEOErb (John L)
员工数量38
证券类型Ordinary Share
年结日Feb 16
公司地址12988 Valley View Rd
城市EDEN PRAIRIE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编55344
电话19523454200
网址https://www.nuwellis.com/
公司代码NUWE
上市日期Feb 16, 2012
CEOErb (John L)

Nuwellis Inc公司高管

名称
名称/职务
职务
持股
持股变动
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 1月2日 周五
更新时间: 1月2日 周五
持股股东
股东类型
持股股东
持股股东
占比
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
其他
91.93%
持股股东
持股股东
占比
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
其他
91.93%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
5.41%
Investment Advisor
2.18%
Hedge Fund
0.40%
Research Firm
0.13%
Individual Investor
0.02%
其他
91.87%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
20
134.31K
8.11%
+91.72K
2025Q3
18
13.52K
2.03%
+10.09K
2025Q2
27
9.97K
1.46%
+7.11K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Sabby Management, LLC
35.89K
2.16%
+32.37K
+918.85%
Sep 30, 2025
DRW Securities, LLC
36.08K
2.18%
+36.08K
--
Sep 30, 2025
Bigger Capital Funds, LP
5.69K
0.34%
+5.69K
--
Jun 09, 2025
Citi Investment Research (US)
1.15K
0.13%
+1.15K
--
Sep 30, 2025
Tower Research Capital LLC
1.03K
0.06%
+898.00
+680.30%
Sep 30, 2025
UBS Financial Services, Inc.
2.86K
0.17%
+979.00
+52.10%
Sep 30, 2025
Erb (John L)
803.00
0.02%
+803.00
--
Jun 10, 2025
SBI Securities Co., Ltd.
63.00
0%
+2.00
+3.28%
Sep 30, 2025
The Vanguard Group, Inc.
31.00
0%
--
--
Nov 30, 2025
BofA Global Research (US)
5.00
0%
+4.00
+400.00%
Sep 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
公告日期
除权除息日
类型
比率
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Oct 17, 2020
Merger
30→1
查看更多
KeyAI